| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.854 | 0.004 | 0.854 | Tumour necrosis factor alpha release inhibitor | 0.81 0.004 DBMET00765 | ||
| 0.767 | 0.02 | 0.767 | Antiinflammatory | 0.698 0.031 DBMET00765 | ||
| 0.763 | 0.021 | 0.787 | Apoptosis agonist | 0.787 0.018 DBMET00765 | DBMET00765 | |
| 0.559 | 0.01 | 0.559 | Hypoxia-inducible factor 1 alpha inhibitor | 0.432 0.023 DBMET00765 | ||
| 0.51 | 0.03 | 0.51 | Immunosuppressant | 0.474 0.04 DBMET00765 | ||
| 0.513 | 0.042 | 0.513 | Transcription factor NF kappa B inhibitor | 0.443 0.054 DBMET00765 | ||
| 0.466 | 0.051 | 0.466 | Antibacterial | 0.434 0.063 DBMET00765 | ||
| 0.471 | 0.072 | 0.471 | Caspase 9 stimulant | 0.4 0.111 DBMET00765 | ||
| 0.308 | 0.02 | 0.308 | Lipocortins synthesis antagonist | 0.286 0.024 DBMET00765 | ||
| 0.336 | 0.05 | 0.336 | Antioxidant | 0.289 0.066 DBMET00765 | ||
| 0.275 | 0.004 | 0.275 | Microtubule formation inhibitor | 0.26 0.006 DBMET00765 | ||
| 0.313 | 0.048 | 0.313 | Free radical scavenger | 0.272 0.06 DBMET00765 | ||
| 0.289 | 0.047 | 0.289 | Antimitotic | 0.208 0.079 DBMET00765 | ||
| 0.284 | 0.044 | 0.29 | Nitric oxide antagonist | 0.29 0.042 DBMET00765 | DBMET00765 | |
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | 0.202 0.031 DBMET00765 | ||
| 0.279 | 0.09 | 0.279 | Caspase 3 stimulant | 0.242 0.119 DBMET00765 | ||
| 0.325 | 0.139 | 0.373 | 5 Hydroxytryptamine release inhibitor | 0.373 0.096 DBMET00765 | DBMET00765 | |
| 0.188 | 0.008 | 0.207 | Vanilloid agonist | 0.207 0.006 DBMET00765 | DBMET00765 | |
| 0.285 | 0.107 | 0.285 | Calcium channel activator | 0.242 0.157 DBMET00765 | ||
| 0.185 | 0.04 | 0.185 | Interleukin 1 antagonist | |||
| 0.201 | 0.063 | 0.202 | P-glycoprotein inhibitor | 0.202 0.063 DBMET00765 | DBMET00765 | |
| 0.222 | 0.088 | 0.222 | Vasodilator | |||
| 0.166 | 0.058 | 0.18 | Protein kinase stimulant | 0.18 0.05 DBMET00765 | DBMET00765 | |
| 0.202 | 0.097 | 0.202 | RNA-directed DNA polymerase inhibitor | 0.18 0.133 DBMET00765 | ||
| 0.169 | 0.068 | 0.233 | Thrombolytic | 0.233 0.038 DBMET00765 | DBMET00765 | |
| 0.164 | 0.065 | 0.171 | Melanin inhibitor | 0.171 0.058 DBMET00765 | DBMET00765 | |
| 0.132 | 0.035 | 0.158 | Antineoplastic antibiotic | 0.158 0.029 DBMET00765 | DBMET00765 | |
| 0.142 | 0.046 | 0.142 | Interleukin 1b antagonist | |||
| 0.213 | 0.127 | 0.213 | 5 Hydroxytryptamine uptake stimulant | 0.209 0.135 DBMET00765 | ||
| 0.121 | 0.039 | 0.121 | Anabolic | 0.116 0.043 DBMET00765 | ||
| 0.131 | 0.051 | 0.141 | Cystathionine beta-synthase inhibitor | 0.141 0.045 DBMET00765 | DBMET00765 | |
| 0.149 | 0.079 | 0.149 | Interferon gamma antagonist | 0.139 0.093 DBMET00765 | ||
| 0.076 | 0.009 | 0.102 | Pregnane X receptor antagonist | 0.102 0.004 DBMET00765 | DBMET00765 | |
| 0.224 | 0.16 | 0.224 | Vasodilator, coronary | |||
| 0.171 | 0.107 | 0.171 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.157 0.134 DBMET00765 | ||
| 0.067 | 0.008 | 0.067 | Microtubule stabilization | 0.061 0.013 DBMET00765 | ||
| 0.084 | 0.026 | 0.084 | Aromatase inhibitor | 0.057 0.044 DBMET00765 | ||
| 0.181 | 0.125 | 0.184 | Nitric-oxide synthase stimulant | 0.184 0.118 DBMET00765 | DBMET00765 | |
| 0.07 | 0.022 | 0.07 | Lipocortins synthesis agonist | 0.066 0.025 DBMET00765 | ||
| 0.087 | 0.048 | 0.087 | Topoisomerase II alpha inhibitor | |||
| 0.138 | 0.1 | 0.138 | CF transmembrane conductance regulator agonist | 0.135 0.107 DBMET00765 | ||
| 0.134 | 0.099 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.132 0.108 DBMET00765 | ||
| 0.117 | 0.083 | 0.117 | Cyclooxygenase 1 inhibitor | |||
| 0.099 | 0.066 | 0.1 | Estrogen receptor beta antagonist | 0.1 0.065 DBMET00765 | DBMET00765 | |
| 0.116 | 0.084 | 0.116 | Cyclooxygenase 2 inhibitor | |||
| 0.108 | 0.08 | 0.108 | Estrogen antagonist | 0.108 0.079 DBMET00765 | ||
| 0.099 | 0.089 | 0.099 | Cholesterol synthesis inhibitor | |||
| 0.016 | 0.009 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.009 DBMET00765 | ||
| 0.038 | 0.034 | 0.038 | Acetyl-CoA carboxylase inhibitor | |||
| 0.181 | 0.178 | 0.181 | Gastrin inhibitor | 0.18 0.179 DBMET00765 | ||
| 0.025 | 0.024 | 0.025 | RNA-directed RNA polymerase stimulant | |||
| 0.058 | 0.064 | 0.06 | Transcription factor RelA inhibitor | 0.06 0.054 DBMET00765 | DBMET00765 | |
| 0.075 | 0.09 | 0.083 | Breast cancer-resistant protein inhibitor | 0.083 0.075 DBMET00765 | DBMET00765 | |
| 0.106 | 0.129 | 0.113 | Vanilloid 1 agonist | 0.113 0.105 DBMET00765 | DBMET00765 | |
| 0.062 | 0.091 | 0.108 | Androgen antagonist | 0.108 0.04 DBMET00765 | DBMET00765 | |
| 0.06 | 0.105 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.05 DBMET00765 | DBMET00765 | |
| 0.01 | 0.627 | 0.157 | Mcl-1 antagonist | 0.157 0.083 DBMET00765 | DBMET00765 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |